Association between the metabolic score for insulin resistance (METS-IR) and estimated glomerular filtration rate (eGFR) among health check-up population in Japan: A retrospective cross-sectional study

Gailing Liu, Tao Lin, Qing Zhu, Xiaojing Jiao, Lei Yan, Fengmin ShaoFrontiers in Endocrinology 2022 · DOI

TL;DR

Researchers have identified a strong negative correlation between the Metabolic Score for Insulin Resistance (METS-IR)—a simple, non-insulin-based metric—and kidney function (eGFR) in a Japanese population. The study suggests that METS-IR could serve as a cost-effective, non-invasive screening tool to identify individuals at high risk for Chronic Kidney Disease (CKD) during routine health check-ups.

What Problem Does This Paper Address?

Chronic Kidney Disease (CKD) is a global health crisis, often remaining asymptomatic until it reaches advanced, life-threatening stages. Early detection is vital, and insulin resistance (IR) is known to be a major driver of kidney decline.

However, measuring IR accurately is difficult. The "gold standard" method—the hyperinsulinemic-euglycemic clamp (HEC)—is invasive, expensive, and impractical for large-scale population screening. While other markers like HOMA-IR exist, they still require fasting insulin assays, which aren't always part of standard blood work. This paper investigates whether METS-IR, a newer score calculated from routine lab values (glucose, triglycerides, HDL cholesterol, and BMI), can effectively signal a decline in the estimated glomerular filtration rate (eGFR), the primary indicator of kidney health.

Methods

The researchers conducted a retrospective cross-sectional study using data from 881 Japanese participants who underwent "human dock" (comprehensive health) screenings between 2004 and 2012.

The core of the study involved calculating the METS-IR for each participant using the following formula: $$Ln[(2 \times \text{Fasting Glucose}) + \text{Fasting Triglycerides}] \times \frac{\text{BMI}}{Ln(\text{HDL-Cholesterol})}$$

They then used multivariate linear regression to analyze the association between this score and eGFR. To ensure the results were robust, the team adjusted for various "confounders"—factors like age, sex, blood pressure, smoking status, and alcohol consumption that might otherwise skew the data.

Datasets

The study utilized a publicly available dataset from the DRYAD database, originally collected from a medical health screening program at the Murakami Memorial Hospital in Gifu, Japan. The final analysis included 881 individuals after excluding participants with missing data or specific health conditions (like hepatitis or abnormal triglyceride levels).

Key Insights and Ideas

  • The "Surrogate" Advantage: The most significant takeaway is that METS-IR—which uses only basic anthropometric and laboratory data—mirrors the results of more complex IR tests. This makes it a highly accessible tool for primary care physicians.
  • Linear Decline: The relationship between metabolic dysfunction and kidney health appears linear. As the METS-IR score climbs, kidney filtration capacity (eGFR) consistently drops.
  • The "Multiplier" Effect: The researchers found significant interaction effects with smoking and uric acid levels. The negative impact of insulin resistance on the kidneys was notably more pronounced in smokers and individuals with hyperuricemia (high uric acid). This suggests that metabolic and lifestyle factors compound to accelerate kidney damage.
  • Stability Across Groups: Interestingly, the association remained consistent regardless of age, sex, or BMI category, suggesting METS-IR is a versatile metric across different demographic subgroups.

Key Results

  • Quantitative Decline: For every 10-unit rise in METS-IR, there was a corresponding 2.54-unit decrease in eGFR (adjusted $\beta = -2.54, P = 0.001$).
  • Quartile Comparison: When participants were divided into four groups based on their METS-IR scores, those in the highest quartile (the most insulin-resistant) had an eGFR that was 5.04 units lower than those in the lowest quartile.
  • Smoking Interaction: In smokers, the association was even stronger ($\beta = -4.84$), highlighting the synergistic damage caused by metabolic stress and tobacco use.

Limitations and Future Work

While the results are promising, the authors acknowledge several limitations:

  1. Cross-Sectional Design: Because the study looks at a single point in time, it can show a correlation but cannot definitively prove that high METS-IR causes the drop in eGFR.
  2. Population Specificity: The cohort was limited to a specific region in Japan (Gifu). It remains to be seen if these exact numerical associations hold true for other ethnic groups with different metabolic profiles.
  3. Lack of Direct Comparison: This specific study did not compare METS-IR directly against the "gold standard" HEC in the same participants.

Future Work: The authors suggest longitudinal studies (tracking participants over many years) to determine if METS-IR can accurately predict the future onset of CKD, potentially allowing for earlier medical intervention.

Summary updated

Abstract

METS-IR is remarkably associated with eGFR among the participants who underwent health check-ups in Gifu, Japan. Although more studies are required to prove it, METS-IR could be applied as a monitoring index for early screening, primary prevention, and diagnostic and treatment management strategies for chronic kidney disease.
BibTeX
@inproceedings{liu2022association,
  author = {Gailing Liu and Tao Lin and Qing Zhu and Xiaojing Jiao and Lei Yan and Fengmin Shao},
  title = {{Association between the metabolic score for insulin resistance (METS-IR) and estimated glomerular filtration rate (eGFR) among health check-up population in Japan: A retrospective cross-sectional study}},
  booktitle = {Frontiers in Endocrinology},
  year = {2022},
  doi = {10.3389/fendo.2022.1027262},
}
Figure